Stimulation of muscle contraction during PRT releases myokines that lower systemic inflammation [121], with 4–8 weeks of PRT reducing serum IL-6 and TNFα in prostate cancer patients [122]. The gene discussed is IL6; the disease is prostate carcinoma.